Plasma Separation in Patients with Bronchial Asthma, Atopic Dermatitis and Hyperimmunoglobulinaemia E
The effect of intensive plasma separation performed eight times within 5 weeks in four patients with atopic dermatitis, bronchial asthma and hyperimmunoglobulinaemia E was followed as regards clinical symptoms and changes in the concentrations of serum (S) IgE, S IgG, S IgA, S IgM, plasma complement...
Ausführliche Beschreibung
Autor*in: |
---|
Format: |
E-Artikel |
---|
Erschienen: |
Oxford, UK: Blackwell Publishing Ltd ; 1984 |
---|
Schlagwörter: |
---|
Umfang: |
Online-Ressource |
---|
Reproduktion: |
2007 ; Blackwell Publishing Journal Backfiles 1879-2005 |
---|---|
Übergeordnetes Werk: |
In: Allergy - Oxford : Blackwell Munksgaard, 1978, 39(1984), 5, Seite 0 |
Übergeordnetes Werk: |
volume:39 ; year:1984 ; number:5 ; pages:0 |
Links: |
---|
DOI / URN: |
10.1111/j.1398-9995.1984.tb01950.x |
---|
Katalog-ID: |
NLEJ239294467 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLEJ239294467 | ||
003 | DE-627 | ||
005 | 20230505191159.0 | ||
007 | cr uuu---uuuuu | ||
008 | 120426s1984 xx |||||o 00| ||und c | ||
024 | 7 | |a 10.1111/j.1398-9995.1984.tb01950.x |2 doi | |
035 | |a (DE-627)NLEJ239294467 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
245 | 1 | 0 | |a Plasma Separation in Patients with Bronchial Asthma, Atopic Dermatitis and Hyperimmunoglobulinaemia E |
264 | 1 | |a Oxford, UK |b Blackwell Publishing Ltd |c 1984 | |
300 | |a Online-Ressource | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a The effect of intensive plasma separation performed eight times within 5 weeks in four patients with atopic dermatitis, bronchial asthma and hyperimmunoglobulinaemia E was followed as regards clinical symptoms and changes in the concentrations of serum (S) IgE, S IgG, S IgA, S IgM, plasma complement C3 split products, S transferrin, blood eosinophils, chemotaxis of neutrophil cells and histamine metabolites in urine in samples obtained consecutively during the period of observation. The occurrence of circulating immune complexes (IC) was analysed by a polyclonal rheumatoid factor (pRF) agglutination inhibition assay and an IgE IC specific technique. IgE 1C were demonstrated in three of the patients prior to plasma separation, complexed IgE was 2–3 % of the total concentration of S IgE. In one patient complexes were detected by the pRF agglutination inhibition assay, also. In the three patients with IgE 1C, the complexes disappeared during treatment, but recurred in two of the patients shortly after the last plasma separation. Shortly after eight separations the S IgE was reduced in all patients to a mean level of 46% of the pre-exchange concentrations. During the following 3 weeks the relative increase of S IgE in three of the patients was similar to the values obtained for S IgG. Serum IgG was subnormal in all patients during the period of treatment. Increasing numbers of eosinophils were observed in three of the patients after the fifth separation procedure. The histamine metabolite 1,4-methylimidazoleacetic (1,4-MIAA) in urine was increased in all patients, but no significant changes were observed during the treatment. The increase of complement C3c split product in two of the patients during the separation procedure indicated that complement activation took place. Questionable clinial improvement of dermatitis and asthma was observed during the period of plasma separation, and the effect was short lasting. For the time being plasma separation in patients with combined hyperimmunoglobulinaemia E, asthma and atopic dermatitis cannot be recommended as a tool in the management of the disease. | ||
533 | |d 2007 |f Blackwell Publishing Journal Backfiles 1879-2005 |7 |2007|||||||||| | ||
650 | 4 | |a atopic dermatitis | |
700 | 1 | |a Nielsen, H. |4 oth | |
700 | 1 | |a Thomsen, B. |4 oth | |
700 | 1 | |a Djurup, R. |4 oth | |
700 | 1 | |a Søndergaard, I. |4 oth | |
700 | 1 | |a Kappelgaard, E. |4 oth | |
700 | 1 | |a Berkowicz, A. |4 oth | |
700 | 1 | |a Kjersem, H. |4 oth | |
700 | 1 | |a Dahlager, J. I. |4 oth | |
700 | 1 | |a Szpirt, W. |4 oth | |
700 | 1 | |a Ullman, S. |4 oth | |
700 | 1 | |a Valerius, N. H. |4 oth | |
700 | 1 | |a Weeke, B. |4 oth | |
773 | 0 | 8 | |i In |t Allergy |d Oxford : Blackwell Munksgaard, 1978 |g 39(1984), 5, Seite 0 |h Online-Ressource |w (DE-627)NLEJ243926979 |w (DE-600)2003114-2 |x 1398-9995 |7 nnns |
773 | 1 | 8 | |g volume:39 |g year:1984 |g number:5 |g pages:0 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/j.1398-9995.1984.tb01950.x |q text/html |x Verlag |z Deutschlandweit zugänglich |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a ZDB-1-DJB | ||
912 | |a GBV_NL_ARTICLE | ||
951 | |a AR | ||
952 | |d 39 |j 1984 |e 5 |h 0 |
matchkey_str |
article:13989995:1984----::lsaeaainnainsihrnhaatmaoidraiiady |
---|---|
hierarchy_sort_str |
1984 |
publishDate |
1984 |
allfields |
10.1111/j.1398-9995.1984.tb01950.x doi (DE-627)NLEJ239294467 DE-627 ger DE-627 rakwb Plasma Separation in Patients with Bronchial Asthma, Atopic Dermatitis and Hyperimmunoglobulinaemia E Oxford, UK Blackwell Publishing Ltd 1984 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The effect of intensive plasma separation performed eight times within 5 weeks in four patients with atopic dermatitis, bronchial asthma and hyperimmunoglobulinaemia E was followed as regards clinical symptoms and changes in the concentrations of serum (S) IgE, S IgG, S IgA, S IgM, plasma complement C3 split products, S transferrin, blood eosinophils, chemotaxis of neutrophil cells and histamine metabolites in urine in samples obtained consecutively during the period of observation. The occurrence of circulating immune complexes (IC) was analysed by a polyclonal rheumatoid factor (pRF) agglutination inhibition assay and an IgE IC specific technique. IgE 1C were demonstrated in three of the patients prior to plasma separation, complexed IgE was 2–3 % of the total concentration of S IgE. In one patient complexes were detected by the pRF agglutination inhibition assay, also. In the three patients with IgE 1C, the complexes disappeared during treatment, but recurred in two of the patients shortly after the last plasma separation. Shortly after eight separations the S IgE was reduced in all patients to a mean level of 46% of the pre-exchange concentrations. During the following 3 weeks the relative increase of S IgE in three of the patients was similar to the values obtained for S IgG. Serum IgG was subnormal in all patients during the period of treatment. Increasing numbers of eosinophils were observed in three of the patients after the fifth separation procedure. The histamine metabolite 1,4-methylimidazoleacetic (1,4-MIAA) in urine was increased in all patients, but no significant changes were observed during the treatment. The increase of complement C3c split product in two of the patients during the separation procedure indicated that complement activation took place. Questionable clinial improvement of dermatitis and asthma was observed during the period of plasma separation, and the effect was short lasting. For the time being plasma separation in patients with combined hyperimmunoglobulinaemia E, asthma and atopic dermatitis cannot be recommended as a tool in the management of the disease. 2007 Blackwell Publishing Journal Backfiles 1879-2005 |2007|||||||||| atopic dermatitis Nielsen, H. oth Thomsen, B. oth Djurup, R. oth Søndergaard, I. oth Kappelgaard, E. oth Berkowicz, A. oth Kjersem, H. oth Dahlager, J. I. oth Szpirt, W. oth Ullman, S. oth Valerius, N. H. oth Weeke, B. oth In Allergy Oxford : Blackwell Munksgaard, 1978 39(1984), 5, Seite 0 Online-Ressource (DE-627)NLEJ243926979 (DE-600)2003114-2 1398-9995 nnns volume:39 year:1984 number:5 pages:0 http://dx.doi.org/10.1111/j.1398-9995.1984.tb01950.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 39 1984 5 0 |
spelling |
10.1111/j.1398-9995.1984.tb01950.x doi (DE-627)NLEJ239294467 DE-627 ger DE-627 rakwb Plasma Separation in Patients with Bronchial Asthma, Atopic Dermatitis and Hyperimmunoglobulinaemia E Oxford, UK Blackwell Publishing Ltd 1984 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The effect of intensive plasma separation performed eight times within 5 weeks in four patients with atopic dermatitis, bronchial asthma and hyperimmunoglobulinaemia E was followed as regards clinical symptoms and changes in the concentrations of serum (S) IgE, S IgG, S IgA, S IgM, plasma complement C3 split products, S transferrin, blood eosinophils, chemotaxis of neutrophil cells and histamine metabolites in urine in samples obtained consecutively during the period of observation. The occurrence of circulating immune complexes (IC) was analysed by a polyclonal rheumatoid factor (pRF) agglutination inhibition assay and an IgE IC specific technique. IgE 1C were demonstrated in three of the patients prior to plasma separation, complexed IgE was 2–3 % of the total concentration of S IgE. In one patient complexes were detected by the pRF agglutination inhibition assay, also. In the three patients with IgE 1C, the complexes disappeared during treatment, but recurred in two of the patients shortly after the last plasma separation. Shortly after eight separations the S IgE was reduced in all patients to a mean level of 46% of the pre-exchange concentrations. During the following 3 weeks the relative increase of S IgE in three of the patients was similar to the values obtained for S IgG. Serum IgG was subnormal in all patients during the period of treatment. Increasing numbers of eosinophils were observed in three of the patients after the fifth separation procedure. The histamine metabolite 1,4-methylimidazoleacetic (1,4-MIAA) in urine was increased in all patients, but no significant changes were observed during the treatment. The increase of complement C3c split product in two of the patients during the separation procedure indicated that complement activation took place. Questionable clinial improvement of dermatitis and asthma was observed during the period of plasma separation, and the effect was short lasting. For the time being plasma separation in patients with combined hyperimmunoglobulinaemia E, asthma and atopic dermatitis cannot be recommended as a tool in the management of the disease. 2007 Blackwell Publishing Journal Backfiles 1879-2005 |2007|||||||||| atopic dermatitis Nielsen, H. oth Thomsen, B. oth Djurup, R. oth Søndergaard, I. oth Kappelgaard, E. oth Berkowicz, A. oth Kjersem, H. oth Dahlager, J. I. oth Szpirt, W. oth Ullman, S. oth Valerius, N. H. oth Weeke, B. oth In Allergy Oxford : Blackwell Munksgaard, 1978 39(1984), 5, Seite 0 Online-Ressource (DE-627)NLEJ243926979 (DE-600)2003114-2 1398-9995 nnns volume:39 year:1984 number:5 pages:0 http://dx.doi.org/10.1111/j.1398-9995.1984.tb01950.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 39 1984 5 0 |
allfields_unstemmed |
10.1111/j.1398-9995.1984.tb01950.x doi (DE-627)NLEJ239294467 DE-627 ger DE-627 rakwb Plasma Separation in Patients with Bronchial Asthma, Atopic Dermatitis and Hyperimmunoglobulinaemia E Oxford, UK Blackwell Publishing Ltd 1984 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The effect of intensive plasma separation performed eight times within 5 weeks in four patients with atopic dermatitis, bronchial asthma and hyperimmunoglobulinaemia E was followed as regards clinical symptoms and changes in the concentrations of serum (S) IgE, S IgG, S IgA, S IgM, plasma complement C3 split products, S transferrin, blood eosinophils, chemotaxis of neutrophil cells and histamine metabolites in urine in samples obtained consecutively during the period of observation. The occurrence of circulating immune complexes (IC) was analysed by a polyclonal rheumatoid factor (pRF) agglutination inhibition assay and an IgE IC specific technique. IgE 1C were demonstrated in three of the patients prior to plasma separation, complexed IgE was 2–3 % of the total concentration of S IgE. In one patient complexes were detected by the pRF agglutination inhibition assay, also. In the three patients with IgE 1C, the complexes disappeared during treatment, but recurred in two of the patients shortly after the last plasma separation. Shortly after eight separations the S IgE was reduced in all patients to a mean level of 46% of the pre-exchange concentrations. During the following 3 weeks the relative increase of S IgE in three of the patients was similar to the values obtained for S IgG. Serum IgG was subnormal in all patients during the period of treatment. Increasing numbers of eosinophils were observed in three of the patients after the fifth separation procedure. The histamine metabolite 1,4-methylimidazoleacetic (1,4-MIAA) in urine was increased in all patients, but no significant changes were observed during the treatment. The increase of complement C3c split product in two of the patients during the separation procedure indicated that complement activation took place. Questionable clinial improvement of dermatitis and asthma was observed during the period of plasma separation, and the effect was short lasting. For the time being plasma separation in patients with combined hyperimmunoglobulinaemia E, asthma and atopic dermatitis cannot be recommended as a tool in the management of the disease. 2007 Blackwell Publishing Journal Backfiles 1879-2005 |2007|||||||||| atopic dermatitis Nielsen, H. oth Thomsen, B. oth Djurup, R. oth Søndergaard, I. oth Kappelgaard, E. oth Berkowicz, A. oth Kjersem, H. oth Dahlager, J. I. oth Szpirt, W. oth Ullman, S. oth Valerius, N. H. oth Weeke, B. oth In Allergy Oxford : Blackwell Munksgaard, 1978 39(1984), 5, Seite 0 Online-Ressource (DE-627)NLEJ243926979 (DE-600)2003114-2 1398-9995 nnns volume:39 year:1984 number:5 pages:0 http://dx.doi.org/10.1111/j.1398-9995.1984.tb01950.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 39 1984 5 0 |
allfieldsGer |
10.1111/j.1398-9995.1984.tb01950.x doi (DE-627)NLEJ239294467 DE-627 ger DE-627 rakwb Plasma Separation in Patients with Bronchial Asthma, Atopic Dermatitis and Hyperimmunoglobulinaemia E Oxford, UK Blackwell Publishing Ltd 1984 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The effect of intensive plasma separation performed eight times within 5 weeks in four patients with atopic dermatitis, bronchial asthma and hyperimmunoglobulinaemia E was followed as regards clinical symptoms and changes in the concentrations of serum (S) IgE, S IgG, S IgA, S IgM, plasma complement C3 split products, S transferrin, blood eosinophils, chemotaxis of neutrophil cells and histamine metabolites in urine in samples obtained consecutively during the period of observation. The occurrence of circulating immune complexes (IC) was analysed by a polyclonal rheumatoid factor (pRF) agglutination inhibition assay and an IgE IC specific technique. IgE 1C were demonstrated in three of the patients prior to plasma separation, complexed IgE was 2–3 % of the total concentration of S IgE. In one patient complexes were detected by the pRF agglutination inhibition assay, also. In the three patients with IgE 1C, the complexes disappeared during treatment, but recurred in two of the patients shortly after the last plasma separation. Shortly after eight separations the S IgE was reduced in all patients to a mean level of 46% of the pre-exchange concentrations. During the following 3 weeks the relative increase of S IgE in three of the patients was similar to the values obtained for S IgG. Serum IgG was subnormal in all patients during the period of treatment. Increasing numbers of eosinophils were observed in three of the patients after the fifth separation procedure. The histamine metabolite 1,4-methylimidazoleacetic (1,4-MIAA) in urine was increased in all patients, but no significant changes were observed during the treatment. The increase of complement C3c split product in two of the patients during the separation procedure indicated that complement activation took place. Questionable clinial improvement of dermatitis and asthma was observed during the period of plasma separation, and the effect was short lasting. For the time being plasma separation in patients with combined hyperimmunoglobulinaemia E, asthma and atopic dermatitis cannot be recommended as a tool in the management of the disease. 2007 Blackwell Publishing Journal Backfiles 1879-2005 |2007|||||||||| atopic dermatitis Nielsen, H. oth Thomsen, B. oth Djurup, R. oth Søndergaard, I. oth Kappelgaard, E. oth Berkowicz, A. oth Kjersem, H. oth Dahlager, J. I. oth Szpirt, W. oth Ullman, S. oth Valerius, N. H. oth Weeke, B. oth In Allergy Oxford : Blackwell Munksgaard, 1978 39(1984), 5, Seite 0 Online-Ressource (DE-627)NLEJ243926979 (DE-600)2003114-2 1398-9995 nnns volume:39 year:1984 number:5 pages:0 http://dx.doi.org/10.1111/j.1398-9995.1984.tb01950.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 39 1984 5 0 |
allfieldsSound |
10.1111/j.1398-9995.1984.tb01950.x doi (DE-627)NLEJ239294467 DE-627 ger DE-627 rakwb Plasma Separation in Patients with Bronchial Asthma, Atopic Dermatitis and Hyperimmunoglobulinaemia E Oxford, UK Blackwell Publishing Ltd 1984 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The effect of intensive plasma separation performed eight times within 5 weeks in four patients with atopic dermatitis, bronchial asthma and hyperimmunoglobulinaemia E was followed as regards clinical symptoms and changes in the concentrations of serum (S) IgE, S IgG, S IgA, S IgM, plasma complement C3 split products, S transferrin, blood eosinophils, chemotaxis of neutrophil cells and histamine metabolites in urine in samples obtained consecutively during the period of observation. The occurrence of circulating immune complexes (IC) was analysed by a polyclonal rheumatoid factor (pRF) agglutination inhibition assay and an IgE IC specific technique. IgE 1C were demonstrated in three of the patients prior to plasma separation, complexed IgE was 2–3 % of the total concentration of S IgE. In one patient complexes were detected by the pRF agglutination inhibition assay, also. In the three patients with IgE 1C, the complexes disappeared during treatment, but recurred in two of the patients shortly after the last plasma separation. Shortly after eight separations the S IgE was reduced in all patients to a mean level of 46% of the pre-exchange concentrations. During the following 3 weeks the relative increase of S IgE in three of the patients was similar to the values obtained for S IgG. Serum IgG was subnormal in all patients during the period of treatment. Increasing numbers of eosinophils were observed in three of the patients after the fifth separation procedure. The histamine metabolite 1,4-methylimidazoleacetic (1,4-MIAA) in urine was increased in all patients, but no significant changes were observed during the treatment. The increase of complement C3c split product in two of the patients during the separation procedure indicated that complement activation took place. Questionable clinial improvement of dermatitis and asthma was observed during the period of plasma separation, and the effect was short lasting. For the time being plasma separation in patients with combined hyperimmunoglobulinaemia E, asthma and atopic dermatitis cannot be recommended as a tool in the management of the disease. 2007 Blackwell Publishing Journal Backfiles 1879-2005 |2007|||||||||| atopic dermatitis Nielsen, H. oth Thomsen, B. oth Djurup, R. oth Søndergaard, I. oth Kappelgaard, E. oth Berkowicz, A. oth Kjersem, H. oth Dahlager, J. I. oth Szpirt, W. oth Ullman, S. oth Valerius, N. H. oth Weeke, B. oth In Allergy Oxford : Blackwell Munksgaard, 1978 39(1984), 5, Seite 0 Online-Ressource (DE-627)NLEJ243926979 (DE-600)2003114-2 1398-9995 nnns volume:39 year:1984 number:5 pages:0 http://dx.doi.org/10.1111/j.1398-9995.1984.tb01950.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 39 1984 5 0 |
source |
In Allergy 39(1984), 5, Seite 0 volume:39 year:1984 number:5 pages:0 |
sourceStr |
In Allergy 39(1984), 5, Seite 0 volume:39 year:1984 number:5 pages:0 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
atopic dermatitis |
isfreeaccess_bool |
false |
container_title |
Allergy |
authorswithroles_txt_mv |
Nielsen, H. @@oth@@ Thomsen, B. @@oth@@ Djurup, R. @@oth@@ Søndergaard, I. @@oth@@ Kappelgaard, E. @@oth@@ Berkowicz, A. @@oth@@ Kjersem, H. @@oth@@ Dahlager, J. I. @@oth@@ Szpirt, W. @@oth@@ Ullman, S. @@oth@@ Valerius, N. H. @@oth@@ Weeke, B. @@oth@@ |
publishDateDaySort_date |
1984-01-01T00:00:00Z |
hierarchy_top_id |
NLEJ243926979 |
id |
NLEJ239294467 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ239294467</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230505191159.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">120426s1984 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1111/j.1398-9995.1984.tb01950.x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ239294467</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Plasma Separation in Patients with Bronchial Asthma, Atopic Dermatitis and Hyperimmunoglobulinaemia E</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford, UK</subfield><subfield code="b">Blackwell Publishing Ltd</subfield><subfield code="c">1984</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The effect of intensive plasma separation performed eight times within 5 weeks in four patients with atopic dermatitis, bronchial asthma and hyperimmunoglobulinaemia E was followed as regards clinical symptoms and changes in the concentrations of serum (S) IgE, S IgG, S IgA, S IgM, plasma complement C3 split products, S transferrin, blood eosinophils, chemotaxis of neutrophil cells and histamine metabolites in urine in samples obtained consecutively during the period of observation. The occurrence of circulating immune complexes (IC) was analysed by a polyclonal rheumatoid factor (pRF) agglutination inhibition assay and an IgE IC specific technique. IgE 1C were demonstrated in three of the patients prior to plasma separation, complexed IgE was 2–3 % of the total concentration of S IgE. In one patient complexes were detected by the pRF agglutination inhibition assay, also. In the three patients with IgE 1C, the complexes disappeared during treatment, but recurred in two of the patients shortly after the last plasma separation. Shortly after eight separations the S IgE was reduced in all patients to a mean level of 46% of the pre-exchange concentrations. During the following 3 weeks the relative increase of S IgE in three of the patients was similar to the values obtained for S IgG. Serum IgG was subnormal in all patients during the period of treatment. Increasing numbers of eosinophils were observed in three of the patients after the fifth separation procedure. The histamine metabolite 1,4-methylimidazoleacetic (1,4-MIAA) in urine was increased in all patients, but no significant changes were observed during the treatment. The increase of complement C3c split product in two of the patients during the separation procedure indicated that complement activation took place. Questionable clinial improvement of dermatitis and asthma was observed during the period of plasma separation, and the effect was short lasting. For the time being plasma separation in patients with combined hyperimmunoglobulinaemia E, asthma and atopic dermatitis cannot be recommended as a tool in the management of the disease.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="d">2007</subfield><subfield code="f">Blackwell Publishing Journal Backfiles 1879-2005</subfield><subfield code="7">|2007||||||||||</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">atopic dermatitis</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nielsen, H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thomsen, B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Djurup, R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Søndergaard, I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kappelgaard, E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berkowicz, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kjersem, H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dahlager, J. I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Szpirt, W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ullman, S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Valerius, N. H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Weeke, B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Allergy</subfield><subfield code="d">Oxford : Blackwell Munksgaard, 1978</subfield><subfield code="g">39(1984), 5, Seite 0</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)NLEJ243926979</subfield><subfield code="w">(DE-600)2003114-2</subfield><subfield code="x">1398-9995</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:39</subfield><subfield code="g">year:1984</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1111/j.1398-9995.1984.tb01950.x</subfield><subfield code="q">text/html</subfield><subfield code="x">Verlag</subfield><subfield code="z">Deutschlandweit zugänglich</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DJB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">39</subfield><subfield code="j">1984</subfield><subfield code="e">5</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
series2 |
Blackwell Publishing Journal Backfiles 1879-2005 |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ243926979 |
format |
electronic Article |
delete_txt_mv |
keep |
collection |
NL |
publishPlace |
Oxford, UK |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
1398-9995 |
topic_title |
Plasma Separation in Patients with Bronchial Asthma, Atopic Dermatitis and Hyperimmunoglobulinaemia E atopic dermatitis |
publisher |
Blackwell Publishing Ltd |
publisherStr |
Blackwell Publishing Ltd |
topic |
misc atopic dermatitis |
spellingShingle |
misc atopic dermatitis Plasma Separation in Patients with Bronchial Asthma, Atopic Dermatitis and Hyperimmunoglobulinaemia E |
topic_unstemmed |
misc atopic dermatitis |
topic_browse |
misc atopic dermatitis |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
h n hn b t bt r d rd i s is e k ek a b ab h k hk j i d ji jid w s ws s u su n h v nh nhv b w bw |
hierarchy_parent_title |
Allergy |
hierarchy_parent_id |
NLEJ243926979 |
hierarchy_top_title |
Allergy |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)NLEJ243926979 (DE-600)2003114-2 |
title |
Plasma Separation in Patients with Bronchial Asthma, Atopic Dermatitis and Hyperimmunoglobulinaemia E |
ctrlnum |
(DE-627)NLEJ239294467 |
title_full |
Plasma Separation in Patients with Bronchial Asthma, Atopic Dermatitis and Hyperimmunoglobulinaemia E |
journal |
Allergy |
journalStr |
Allergy |
isOA_bool |
false |
recordtype |
marc |
publishDateSort |
1984 |
contenttype_str_mv |
zzz |
container_start_page |
0 |
container_volume |
39 |
physical |
Online-Ressource |
format_se |
Elektronische Aufsätze |
doi_str_mv |
10.1111/j.1398-9995.1984.tb01950.x |
title_sort |
plasma separation in patients with bronchial asthma, atopic dermatitis and hyperimmunoglobulinaemia e |
title_auth |
Plasma Separation in Patients with Bronchial Asthma, Atopic Dermatitis and Hyperimmunoglobulinaemia E |
abstract |
The effect of intensive plasma separation performed eight times within 5 weeks in four patients with atopic dermatitis, bronchial asthma and hyperimmunoglobulinaemia E was followed as regards clinical symptoms and changes in the concentrations of serum (S) IgE, S IgG, S IgA, S IgM, plasma complement C3 split products, S transferrin, blood eosinophils, chemotaxis of neutrophil cells and histamine metabolites in urine in samples obtained consecutively during the period of observation. The occurrence of circulating immune complexes (IC) was analysed by a polyclonal rheumatoid factor (pRF) agglutination inhibition assay and an IgE IC specific technique. IgE 1C were demonstrated in three of the patients prior to plasma separation, complexed IgE was 2–3 % of the total concentration of S IgE. In one patient complexes were detected by the pRF agglutination inhibition assay, also. In the three patients with IgE 1C, the complexes disappeared during treatment, but recurred in two of the patients shortly after the last plasma separation. Shortly after eight separations the S IgE was reduced in all patients to a mean level of 46% of the pre-exchange concentrations. During the following 3 weeks the relative increase of S IgE in three of the patients was similar to the values obtained for S IgG. Serum IgG was subnormal in all patients during the period of treatment. Increasing numbers of eosinophils were observed in three of the patients after the fifth separation procedure. The histamine metabolite 1,4-methylimidazoleacetic (1,4-MIAA) in urine was increased in all patients, but no significant changes were observed during the treatment. The increase of complement C3c split product in two of the patients during the separation procedure indicated that complement activation took place. Questionable clinial improvement of dermatitis and asthma was observed during the period of plasma separation, and the effect was short lasting. For the time being plasma separation in patients with combined hyperimmunoglobulinaemia E, asthma and atopic dermatitis cannot be recommended as a tool in the management of the disease. |
abstractGer |
The effect of intensive plasma separation performed eight times within 5 weeks in four patients with atopic dermatitis, bronchial asthma and hyperimmunoglobulinaemia E was followed as regards clinical symptoms and changes in the concentrations of serum (S) IgE, S IgG, S IgA, S IgM, plasma complement C3 split products, S transferrin, blood eosinophils, chemotaxis of neutrophil cells and histamine metabolites in urine in samples obtained consecutively during the period of observation. The occurrence of circulating immune complexes (IC) was analysed by a polyclonal rheumatoid factor (pRF) agglutination inhibition assay and an IgE IC specific technique. IgE 1C were demonstrated in three of the patients prior to plasma separation, complexed IgE was 2–3 % of the total concentration of S IgE. In one patient complexes were detected by the pRF agglutination inhibition assay, also. In the three patients with IgE 1C, the complexes disappeared during treatment, but recurred in two of the patients shortly after the last plasma separation. Shortly after eight separations the S IgE was reduced in all patients to a mean level of 46% of the pre-exchange concentrations. During the following 3 weeks the relative increase of S IgE in three of the patients was similar to the values obtained for S IgG. Serum IgG was subnormal in all patients during the period of treatment. Increasing numbers of eosinophils were observed in three of the patients after the fifth separation procedure. The histamine metabolite 1,4-methylimidazoleacetic (1,4-MIAA) in urine was increased in all patients, but no significant changes were observed during the treatment. The increase of complement C3c split product in two of the patients during the separation procedure indicated that complement activation took place. Questionable clinial improvement of dermatitis and asthma was observed during the period of plasma separation, and the effect was short lasting. For the time being plasma separation in patients with combined hyperimmunoglobulinaemia E, asthma and atopic dermatitis cannot be recommended as a tool in the management of the disease. |
abstract_unstemmed |
The effect of intensive plasma separation performed eight times within 5 weeks in four patients with atopic dermatitis, bronchial asthma and hyperimmunoglobulinaemia E was followed as regards clinical symptoms and changes in the concentrations of serum (S) IgE, S IgG, S IgA, S IgM, plasma complement C3 split products, S transferrin, blood eosinophils, chemotaxis of neutrophil cells and histamine metabolites in urine in samples obtained consecutively during the period of observation. The occurrence of circulating immune complexes (IC) was analysed by a polyclonal rheumatoid factor (pRF) agglutination inhibition assay and an IgE IC specific technique. IgE 1C were demonstrated in three of the patients prior to plasma separation, complexed IgE was 2–3 % of the total concentration of S IgE. In one patient complexes were detected by the pRF agglutination inhibition assay, also. In the three patients with IgE 1C, the complexes disappeared during treatment, but recurred in two of the patients shortly after the last plasma separation. Shortly after eight separations the S IgE was reduced in all patients to a mean level of 46% of the pre-exchange concentrations. During the following 3 weeks the relative increase of S IgE in three of the patients was similar to the values obtained for S IgG. Serum IgG was subnormal in all patients during the period of treatment. Increasing numbers of eosinophils were observed in three of the patients after the fifth separation procedure. The histamine metabolite 1,4-methylimidazoleacetic (1,4-MIAA) in urine was increased in all patients, but no significant changes were observed during the treatment. The increase of complement C3c split product in two of the patients during the separation procedure indicated that complement activation took place. Questionable clinial improvement of dermatitis and asthma was observed during the period of plasma separation, and the effect was short lasting. For the time being plasma separation in patients with combined hyperimmunoglobulinaemia E, asthma and atopic dermatitis cannot be recommended as a tool in the management of the disease. |
collection_details |
GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE |
container_issue |
5 |
title_short |
Plasma Separation in Patients with Bronchial Asthma, Atopic Dermatitis and Hyperimmunoglobulinaemia E |
url |
http://dx.doi.org/10.1111/j.1398-9995.1984.tb01950.x |
remote_bool |
true |
author2 |
Nielsen, H. Thomsen, B. Djurup, R. Søndergaard, I. Kappelgaard, E. Berkowicz, A. Kjersem, H. Dahlager, J. I. Szpirt, W. Ullman, S. Valerius, N. H. Weeke, B. |
author2Str |
Nielsen, H. Thomsen, B. Djurup, R. Søndergaard, I. Kappelgaard, E. Berkowicz, A. Kjersem, H. Dahlager, J. I. Szpirt, W. Ullman, S. Valerius, N. H. Weeke, B. |
ppnlink |
NLEJ243926979 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth |
doi_str |
10.1111/j.1398-9995.1984.tb01950.x |
up_date |
2024-07-06T07:08:30.585Z |
_version_ |
1803812560529522688 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ239294467</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230505191159.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">120426s1984 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1111/j.1398-9995.1984.tb01950.x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ239294467</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Plasma Separation in Patients with Bronchial Asthma, Atopic Dermatitis and Hyperimmunoglobulinaemia E</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford, UK</subfield><subfield code="b">Blackwell Publishing Ltd</subfield><subfield code="c">1984</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The effect of intensive plasma separation performed eight times within 5 weeks in four patients with atopic dermatitis, bronchial asthma and hyperimmunoglobulinaemia E was followed as regards clinical symptoms and changes in the concentrations of serum (S) IgE, S IgG, S IgA, S IgM, plasma complement C3 split products, S transferrin, blood eosinophils, chemotaxis of neutrophil cells and histamine metabolites in urine in samples obtained consecutively during the period of observation. The occurrence of circulating immune complexes (IC) was analysed by a polyclonal rheumatoid factor (pRF) agglutination inhibition assay and an IgE IC specific technique. IgE 1C were demonstrated in three of the patients prior to plasma separation, complexed IgE was 2–3 % of the total concentration of S IgE. In one patient complexes were detected by the pRF agglutination inhibition assay, also. In the three patients with IgE 1C, the complexes disappeared during treatment, but recurred in two of the patients shortly after the last plasma separation. Shortly after eight separations the S IgE was reduced in all patients to a mean level of 46% of the pre-exchange concentrations. During the following 3 weeks the relative increase of S IgE in three of the patients was similar to the values obtained for S IgG. Serum IgG was subnormal in all patients during the period of treatment. Increasing numbers of eosinophils were observed in three of the patients after the fifth separation procedure. The histamine metabolite 1,4-methylimidazoleacetic (1,4-MIAA) in urine was increased in all patients, but no significant changes were observed during the treatment. The increase of complement C3c split product in two of the patients during the separation procedure indicated that complement activation took place. Questionable clinial improvement of dermatitis and asthma was observed during the period of plasma separation, and the effect was short lasting. For the time being plasma separation in patients with combined hyperimmunoglobulinaemia E, asthma and atopic dermatitis cannot be recommended as a tool in the management of the disease.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="d">2007</subfield><subfield code="f">Blackwell Publishing Journal Backfiles 1879-2005</subfield><subfield code="7">|2007||||||||||</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">atopic dermatitis</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nielsen, H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thomsen, B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Djurup, R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Søndergaard, I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kappelgaard, E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berkowicz, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kjersem, H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dahlager, J. I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Szpirt, W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ullman, S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Valerius, N. H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Weeke, B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Allergy</subfield><subfield code="d">Oxford : Blackwell Munksgaard, 1978</subfield><subfield code="g">39(1984), 5, Seite 0</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)NLEJ243926979</subfield><subfield code="w">(DE-600)2003114-2</subfield><subfield code="x">1398-9995</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:39</subfield><subfield code="g">year:1984</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1111/j.1398-9995.1984.tb01950.x</subfield><subfield code="q">text/html</subfield><subfield code="x">Verlag</subfield><subfield code="z">Deutschlandweit zugänglich</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DJB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">39</subfield><subfield code="j">1984</subfield><subfield code="e">5</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
score |
7.400939 |